Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Toxic watchdog BAN Toxics has once again called out popular online shopping platforms Lazada and Shopee for allowing the ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

The FDA in 2016 granted accelerated approval to the FXR agonist as a second-line treatment for adults with PBC, either in ...

TrakCel, a provider of integrated cell and gene therapy (CGT) orchestration solutions for the precise management, control and tracking of CGTs has today announced that its orchestration platform ...

Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...

Scemblix (asciminib) is a new first-line option for adults with newly diagnosed Philadelphia chromosome-positive chronic ...

Canalevia®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDABy prescription only, Canalevia-CA1 is a canine-specific ...

Though HIWU classifies Hemo 15 as a banned substance, Dr. Shell claims he operated under the impression that it was a ...

Quarterback Matthew Sluka, who left UNLV three games into the season over a name, image and likeness dispute, has entered the ...

Generic drugs prescribed for heart patients ­covered by the government are as safe and effective as branded drugs, says ...

The FDA officially deemed the nearly two-year shortage ... Welch logged into his wholesaler portal and was surprised to see "zero allocation" for Mounjaro and Zepbound, meaning he was still ...